V
66
4
CB
57
3
ITW
58
2
PNW
66
2
ABT
50
2
HON
70
-9
ORCL
67
2
VLO
62
2
CMI
52
-3
ES
49
2
FAST
55
2
UPS
41
-4
MO
60
3
CRM
59
5
GE
71
3
TRIP
70
10
ADSK
63
2
PYPL
74
2
EQT
57
-2
CL
72
14
V
66
4
CB
57
3
ITW
58
2
PNW
66
2
ABT
50
2
HON
70
-9
ORCL
67
2
VLO
62
2
CMI
52
-3
ES
49
2
FAST
55
2
UPS
41
-4
MO
60
3
CRM
59
5
GE
71
3
TRIP
70
10
ADSK
63
2
PYPL
74
2
EQT
57
-2
CL
72
14
Financhill
Back

Corcept Therapeutics Stock Predictions

One Tool. Personalized Setups.

Try it here.
Sell
49

CORT
Corcept Therapeutics

Last Price:
$72.39
Seasonality Move:
7.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Your Summer Trading Shortcut

Try it free today.

Corcept Therapeutics Stock Forecast

  • Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 29.9% based on the past 21 years of stock performance.
  • Corcept Therapeutics has risen higher in 12 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%
  • Is Corcept Therapeutics Stock Undervalued?
    The current Corcept Therapeutics [CORT] share price is $72.27. The Score for CORT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CORT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Corcept Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 29.9% based on the past 21 years of stock performance.

Corcept Therapeutics Stock Rating

Sell
49
Corcept Therapeutics (CORT) is a Sell

Is Corcept Therapeutics overpriced?

  • Corcept Therapeutics has risen higher in 12 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.14%

Corcept Therapeutics Stock Price History

Is CORT stock going to rise?

  • The current trend is relatively stagnant and CORT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com

52-Week Data

52-Week High:
117.33
52-Week Low:
29.42

Prediction Charts

Market Cap:
7.7B
Price in USD:
72.27
Volume:
675.8K
Beta:
0.77

Technical Analysis

SMA50:
72.65
SMA100:
69.06
SMA200:
60.62
52-Wk Change:
136.95%

Stock Predictions

  • Is Corcept Therapeutics stock public?
    Yes, Corcept Therapeutics is a publicly traded company.
  • What is the Corcept Therapeutics stock quote today?
    The Corcept Therapeutics stock price is 72.27 USD today.
  • How to buy Corcept Therapeutics stock online?
    You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-13 69.84 70.06 70.95 69.38
Jun-16 70.72 70.90 71.07 69.92
Jun-17 69.88 71.85 72.55 69.60
Jun-18 72.04 71.24 73.13 70.78
Jun-20 71.24 71.38 72.00 69.47
Jun-23 71.38 74.28 74.40 71.00
Jun-24 75.07 76.77 77.42 73.33
Jun-25 77.03 73.99 77.16 73.72
Jun-26 73.98 74.33 74.43 72.48
Jun-27 75.13 73.22 75.95 72.98
Jun-30 73.60 73.40 73.81 71.74
Jul-1 73.30 69.31 73.80 69.28
Jul-2 69.12 71.34 71.57 68.52
Jul-3 71.63 72.27 72.72 71.45

Corcept Therapeutics Earnings

Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Corcept Therapeutics Forecast Revenue Growth

Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.03 per share, and an increase next year of $1.28 per share.

* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.